+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neglected Tropical Diseases Diagnosis Market - Global Forecast 2025-2030- Product Image
Neglected Tropical Diseases Diagnosis Market - Global Forecast 2025-2030- Product Image
Sale

Neglected Tropical Diseases Diagnosis Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715593
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Neglected Tropical Diseases Diagnosis Market is quickly evolving as healthcare stakeholders prioritize early detection and intervention for underrecognized infectious threats. Driven by a confluence of technical advances and collaborative action, the sector is moving toward integrated, resilient diagnostics solutions worldwide.

Market Snapshot: Neglected Tropical Diseases Diagnosis Market

The Neglected Tropical Diseases Diagnosis Market grew from USD 7.04 billion in 2024 to USD 7.47 billion in 2025. It is expected to continue growing at a CAGR of 5.89%, reaching USD 9.94 billion by 2030. Demand is rising for innovative solutions that address the diagnostic needs of resource-constrained environments and support scalable disease management. Investments are targeting actionable technologies, while policy and tariff dynamics shape the supply landscape for leading manufacturers and end users.

Scope & Segmentation

  • Technology: Immunoassays (Chemiluminescence Assay, Enzyme Linked Immunosorbent Assay), Microscopy (Fluorescence, Light), Molecular Diagnostics (Isothermal Amplification, Polymerase Chain Reaction), Rapid Diagnostic Tests (Antibody Detection, Antigen Detection)
  • Disease Type: Chagas Disease (ELISA, PCR), Leishmaniasis (Cutaneous, Visceral Tests), Lymphatic Filariasis (Antibody Detection, Immunochromatographic Test), Onchocerciasis (PCR, Skin Snip Microscopy), Schistosomiasis (Stool Microscopy, Urine Antigen Test)
  • End User: Community Health Clinics, Primary Care Centers, Diagnostic Laboratories (Independent, Reference), Hospitals (Private, Public), Research Institutes
  • Application: Confirmatory Testing (Lab or Point of Care), Screening (Community, Mass Drug Administration), Surveillance (Epidemiological, Post-Elimination)
  • Sample Type: Blood (Serum Plasma, Whole Blood), Stool (Concentration Technique, Direct Smear), Tissue (Biopsy, Skin Snip), Urine (Concentrated, Direct Test)
  • Region: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, Nigeria, Egypt, South Africa, UAE, Saudi Arabia), Asia-Pacific (China, India, Japan, Australia, Indonesia, and others)
  • Key Companies: F. Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, bioMérieux SA, QIAGEN GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Hologic, Inc., Coris BioConcept SA

Key Takeaways: Market Dynamics & Strategic Insights

  • Rapid progress in diagnostic platforms is enabling earlier detection and improved patient management for diseases historically underdiagnosed in low-resource regions.
  • Collaboration among government bodies, academia, and private industry accelerates innovation, particularly for translating breakthrough assays into scalable point-of-care applications.
  • Shifting end-user preferences emphasize resilience, affordability, and supply chain adaptability as much as analytical accuracy and turnaround times.
  • Digital advances, including AI and real-time data platforms, are enhancing result interpretation, streamlining disease tracking, and enabling targeted outbreak response.
  • Regional adoption is shaped by a combination of local infrastructure, donor-supported initiatives, and emerging partnerships aimed at building sustainable diagnostic capacity and training programs.
  • New entrants and competitive pressures are encouraging legacy companies to iterate product offerings quickly and integrate interdisciplinary solutions.

Tariff Impact: Navigating Cost and Logistics Challenges

Recent United States tariff adjustments have introduced new challenges for diagnostic supply chains. Higher duties on assay components and reagents are raising production costs and prompting adaptation in sourcing strategies. Manufacturers and healthcare providers are diversifying procurement and emphasizing localization to safeguard diagnostic access in susceptible markets. Enhanced warehousing and creative financing collaborations are being implemented to buffer against delays and cost increases in regional diagnostics delivery.

Methodology & Data Sources

This report applies a multi-tiered approach, integrating primary interviews with diagnostic experts and direct end users with secondary reviews of peer-reviewed publications and industry data. Findings are supported by cross-referenced performance metrics and real-world field observations, ensuring evidence-based insights into market direction and operational challenges.

Why This Report Matters

  • Provides validated, actionable intelligence to guide investment, strategic planning, and operational decision-making in the Neglected Tropical Diseases Diagnosis Market.
  • Enables benchmarking of technology adoption, supply chain strategies, and partnership models across diverse regional contexts.
  • Supports regulatory and procurement teams in navigating evolving policy environments and achieving sustainable health outcomes.

Conclusion

With disease management needs intensifying and global partnerships expanding, stakeholders require nuanced insights to drive innovation and achieve effective diagnostic coverage. This analysis positions decision-makers to align strategy, optimize investments, and advance global elimination initiatives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid expansion of multiplex point-of-care diagnostic platforms integrating AI-driven image analysis for multiple neglected tropical diseases
5.2. Growing adoption of CRISPR-based diagnostic assays enabling ultra-sensitive detection of tropical disease pathogens in low-resource settings
5.3. Development of portable molecular diagnostic devices leveraging isothermal amplification for field-level surveillance of neglected tropical infections
5.4. Increasing partnerships between public health agencies and biotech firms to deploy next-generation diagnostics in remote endemic regions
5.5. Emergence of smartphone-enabled microscopy apps using machine learning to accurately identify parasite species in point-of-need scenarios
5.6. Scaling up of community-based serological screening programs supported by rapid lateral flow immunoassays for early detection of NTDs
5.7. Integration of cloud-connected diagnostic kiosks for real-time data collection and epidemiological mapping of neglected tropical diseases
5.8. Innovation in multiplex ELISA kits for simultaneous quantification of multiple neglected tropical disease biomarkers in serum samples
5.9. Regulatory advances facilitating accelerated approval pathways for novel NTD diagnostic tools in highly burdened low-income countries
5.10. Expansion of mobile laboratory networks offering DNA-based pathogen detection in outbreak hotspots of tropical disease endemic areas
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Neglected Tropical Diseases Diagnosis Market, by Technology
8.1. Introduction
8.2. Immunoassays
8.2.1. Chemiluminescence Assay
8.2.2. Enzyme Linked Immunosorbent Assay
8.3. Microscopy
8.3.1. Fluorescence Microscopy
8.3.2. Light Microscopy
8.4. Molecular Diagnostics
8.4.1. Isothermal Amplification
8.4.2. Polymerase Chain Reaction
8.5. Rapid Diagnostic Tests
8.5.1. Antibody Detection
8.5.2. Antigen Detection
9. Neglected Tropical Diseases Diagnosis Market, by Disease Type
9.1. Introduction
9.2. Chagas Disease
9.2.1. Enzyme Linked Immunosorbent Assay
9.2.2. Polymerase Chain Reaction
9.3. Leishmaniasis
9.3.1. Cutaneous Leishmaniasis Tests
9.3.2. Visceral Leishmaniasis Tests
9.4. Lymphatic Filariasis
9.4.1. Antibody Detection Test
9.4.2. Immunochromatographic Test
9.5. Onchocerciasis
9.5.1. Polymerase Chain Reaction
9.5.2. Skin Snip Microscopy
9.6. Schistosomiasis
9.6.1. Stool Microscopy
9.6.2. Urine Antigen Test
10. Neglected Tropical Diseases Diagnosis Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Community Health Centers
10.2.2. Primary Care Clinics
10.3. Diagnostic Laboratories
10.3.1. Independent Laboratories
10.3.2. Reference Laboratories
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Research Institutes
11. Neglected Tropical Diseases Diagnosis Market, by Application
11.1. Introduction
11.2. Confirmatory Testing
11.2.1. Laboratory Confirmation
11.2.2. Point Of Care Confirmation
11.3. Screening
11.3.1. Community Screening
11.3.2. Mass Drug Administration Screening
11.4. Surveillance
11.4.1. Epidemiological Surveillance
11.4.2. Post Elimination Surveillance
12. Neglected Tropical Diseases Diagnosis Market, by Sample Type
12.1. Introduction
12.2. Blood
12.2.1. Serum Plasma
12.2.2. Whole Blood
12.3. Stool
12.3.1. Concentration Technique
12.3.2. Direct Smear
12.4. Tissue
12.4.1. Biopsy
12.4.2. Skin Snip
12.5. Urine
12.5.1. Concentrated Urine Test
12.5.2. Direct Urine Test
13. Americas Neglected Tropical Diseases Diagnosis Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Neglected Tropical Diseases Diagnosis Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Neglected Tropical Diseases Diagnosis Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche AG
16.3.2. Abbott Laboratories
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Danaher Corporation
16.3.5. bioMérieux SA
16.3.6. QIAGEN GmbH
16.3.7. Becton, Dickinson and Company
16.3.8. Bio-Rad Laboratories, Inc.
16.3.9. Hologic, Inc.
16.3.10. Coris BioConcept SA
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: RESEARCHAI
FIGURE 26. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: RESEARCHSTATISTICS
FIGURE 27. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: RESEARCHCONTACTS
FIGURE 28. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHEMILUMINESCENCE ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHEMILUMINESCENCE ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LIGHT MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LIGHT MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ANTIBODY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ANTIBODY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ANTIGEN DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ANTIGEN DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CUTANEOUS LEISHMANIASIS TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CUTANEOUS LEISHMANIASIS TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY VISCERAL LEISHMANIASIS TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY VISCERAL LEISHMANIASIS TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ANTIBODY DETECTION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ANTIBODY DETECTION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOCHROMATOGRAPHIC TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SKIN SNIP MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SKIN SNIP MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE ANTIGEN TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE ANTIGEN TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COMMUNITY HEALTH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LABORATORY CONFIRMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LABORATORY CONFIRMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POINT OF CARE CONFIRMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POINT OF CARE CONFIRMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTING, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTING, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COMMUNITY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COMMUNITY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MASS DRUG ADMINISTRATION SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MASS DRUG ADMINISTRATION SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POST ELIMINATION SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POST ELIMINATION SURVEILLANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERUM PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERUM PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONCENTRATION TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONCENTRATION TECHNIQUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIRECT SMEAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIRECT SMEAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SKIN SNIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SKIN SNIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONCENTRATED URINE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONCENTRATED URINE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIRECT URINE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIRECT URINE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTING, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTING, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MICROSCOPY, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTING, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTING, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCREENING, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCREENING, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SURVEILLANCE, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SURVEILLANCE, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 265. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL, 2018-2024 (USD MILLION)
TABLE 266. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STOOL, 2025-2030 (USD MILLION)
TABLE 267. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 268. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 269. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE, 2018-2024 (USD MILLION)
TABLE 270. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY URINE, 2025-2030 (USD MILLION)
TABLE 271. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 272. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 273. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 276. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 277. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MICROSCOPY, 2018-2024 (USD MILLION)
TABLE 278. CANADA NEGLECTED TROPICAL DISEASES

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Neglected Tropical Diseases Diagnosis market report include:
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • bioMérieux SA
  • QIAGEN GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Hologic, Inc.
  • Coris BioConcept SA

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.94 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease, By Diagnostic Method, By Service Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report By Disease, By Diagnostic Method, By Service Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Neglected Tropical Diseases Diagnosis - Global Strategic Business Report - Product Image

Neglected Tropical Diseases Diagnosis - Global Strategic Business Report

  • Report
  • 360 Pages
  • Global
From
Neglected Tropical Diseases Diagnosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Neglected Tropical Diseases Diagnosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Advances in the Medicinal Chemistry of Neglected Tropical Disease and Related Infectious Diseases - Product Image

Advances in the Medicinal Chemistry of Neglected Tropical Disease and Related Infectious Diseases

  • Book
From
Hunter's Tropical Medicine and Emerging Infectious Diseases. Edition No. 10 - Product Image

Hunter's Tropical Medicine and Emerging Infectious Diseases. Edition No. 10

  • Book

About the Neglected Tropical Diseases Diagnosis Market

Neglected Tropical Diseases (NTDs) Diagnosis is a subset of the Infectious Disease Testing market. NTDs are a group of diseases that disproportionately affect the world’s poorest populations, and are caused by a variety of pathogens, including bacteria, viruses, and parasites. Diagnosis of NTDs is typically done through a combination of clinical symptoms, laboratory tests, and imaging. Diagnostic tests for NTDs are often limited in availability and accuracy, and are often expensive and difficult to access in resource-limited settings. In recent years, there has been an increased focus on the development of new diagnostic tests for NTDs, with the aim of improving access to diagnosis and treatment. This has led to the emergence of a number of companies offering NTD diagnostic tests, including Cepheid, BioMérieux, and Qiagen. Other companies, such as Alere, have developed point-of-care tests for NTDs, which can provide rapid diagnosis in resource-limited settings. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.